LPAR1 and obstructive sleep apnea syndrome: Furthermore, similar studies have established polymorphisms in tumor necrosis factor-a (TNF-a), prostaglandin E2 receptor EP3 subtype (PTGER3), and Lysophosphatidic acid receptor 1 (LPAR1) to be a risk factor associated with OSA [35,36].